Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Toll-like receptor 2-Toll-like receptor 6 (TLR2/TLR6) complex is a cell-surface pattern recognition receptor (PRR) heterodimer that plays a critical role in the innate immune system. It is primarily expressed on immune cells such as macrophages, monocytes, dendritic cells, and neutrophils, where it recognizes diacylated lipopeptides and other pathogen-associated molecular patterns (PAMPs) from Gram-positive bacteria, mycoplasma, fungi, and viruses. Upon ligand binding, the TLR2/TLR6 complex recruits the adaptor proteins MyD88 and TIRAP/MAL, initiating a signaling cascade that activates the NF-κB and MAPK pathways, leading to the production of pro-inflammatory cytokines and chemokines. In therapeutic development, TLR2/TLR6 agonists like FSL-1, Pam2CSK4, and GSK3277329 are being investigated as vaccine adjuvants, immunotherapies for cancer, and countermeasures for radiation-induced hematopoietic injury. Conversely, TLR2/TLR6 antagonists are being explored to mitigate hyperinflammatory conditions, viral-induced cytokine storms, and autoimmune diseases. However, targeting this complex requires careful management of safety concerns, particularly the risk of inducing systemic inflammatory responses or cytokine release syndrome.
Agonist or antagonist of the Toll-like receptor 2/6 complex, modulating downstream MyD88-dependent signaling pathways.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 2-Toll-like receptor 6 complex (TLR2/TLR6).